Compare Amphastar Pharmaceuticals Inc (AMPH) vs Nokia Corp (NOK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amphastar Pharmaceuticals Inc vs Nokia Corp — how do they compare? Amphastar Pharmaceuticals Inc trades at $20.39 (market cap $868.62M), while Nokia Corp trades at $10.2 (market cap $53.00B). The key difference: Nokia Corp is far larger — about 61× Amphastar Pharmaceuticals Inc's market cap, and Nokia Corp pays a 1.73% dividend while Amphastar Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMPH | NOK | |
|---|---|---|
Market Cap | $868.62M | $53.00B |
Sector | Health | Technology |
52-Week High | $30.81 | $16.83 |
52-Week Low | $16.87 | $4.13 |
Enterprise Value | $1.27B | $50.95B |
Dividend Yield | — | 1.73% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amphastar Pharmaceuticals Inc
Amphastar is a specialty pharmaceutical company that develops and markets injectable, intranasal, and inhalation products. Its portfolio includes both complex generic drugs and proprietary delivery systems.
Read more on AMPH →About Nokia Corp
Nokia is a leading vendor in the telecommunications equipment industry. The company's network business derives revenue from selling wireless and fixed-line hardware, software, and services. Nokia's technology segment licenses its patent portfolio to handset manufacturers and makes royalties from Nokia-branded cellphones. The company, headquartered in Espoo, Finland, operates on a global scale, with most of its revenue from communication service providers.
Read more on NOK →
